6WIA
CRYSTAL STRUCTURE OF HUMAN PROTECTIVE PROTEIN/CATHEPSIN A, DFP-INHIBITED (AGED)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SEALED TUBE |
Source details | BRUKER D8 QUEST |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2018-11-09 |
Detector | Bruker PHOTON III |
Wavelength(s) | 1.54 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 91.273, 101.999, 48.114 |
Unit cell angles | 90.00, 101.61, 90.00 |
Refinement procedure
Resolution | 41.700 - 2.210 |
R-factor | 0.1962 |
Rwork | 0.195 |
R-free | 0.22350 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4az3 |
RMSD bond length | 0.011 |
RMSD bond angle | 1.539 |
Data reduction software | APEX |
Data scaling software | APEX |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0258) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 41.700 | 2.310 |
High resolution limit [Å] | 2.210 | 2.210 |
Rmerge | 0.084 | 0.391 |
Number of reflections | 21594 | 2654 |
<I/σ(I)> | 11.55 | 3.36 |
Completeness [%] | 99.8 | 99.8 |
Redundancy | 5.12 | 5.05 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 4.6 | 277 | Crystallized in Crystal Screen Cryo II condition #12 (0.095 M cadmium chloride hydrate, 0.095 M sodium acetate trihydrate pH 4.6, 28.5% v/v PEG 400, 5% glycerol). Mounted in 30% glycerol and 70% CS Cryo II condition #12. Protein was inhibited with DFP in 25 mM Tris pH 8, 300 mM NaCl at R.T. |